Three patients with Candida auris resistant to all three classes of antifungals commonly prescribed for the illness have been identified through active and ongoing surveillance in New York, according to findings published in MMWR.

Date: January 10, 2020

Source: Healio Infectious Disease News

Author: Ostrowsky B, et al.

Excerpt: “Isolates obtained later from infected patients with susceptibilities demonstrated that 330 of 331 (99.7%) were resistant to fluconazole, 210 of 331 (63.4%) were resistant to amphotericin B and 13 of 331 (3.9%) were resistant to echinocandins. Three of these patients were found to have pan-resistant C. auris that reportedly developed after receiving antifungal medications, including echinocandins.”